WallStreetZenWallStreetZen

NASDAQ: PODD
Insulet Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Insulet earnings were $236.1M for the trailing 12 months ending Jun 30, 2025, with -40.4% growth year over year. The latest PODD earnings report on Jun 30, 2025 announced Q2 2025 earnings of $22.5M, down 36.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PODD reported annual earnings of $418.3M, with 102.8% growth. The next PODD earnings date is Nov 6, 2025.

PODD past earnings growth

How has PODD's earnings growth performed historically?

Company
-40.35%
Industry
84.35%
Market
34.06%
PODD's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PODD's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
PODD's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

PODD earnings history

Current Revenue
$2.4B
Current Earnings
$236.1M
Current Profit Margin
10%

PODD Return on Equity

Current Company
18.4%
Current Industry
15.2%
Current Market
30.7%
PODD's Return on Equity (18.4%)... subscribe to Premium to read more.
High Return on Equity Performance

PODD undefined

Current Company
7.2%
Current Industry
8.9%
PODD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PODD announces earnings.

PODD undefined

Current Company
13.03%
Current Industry
10.6%
PODD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PODD vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PODD$407.30M$236.10M+64.47%$3.37
STE$1.40B$646.64M+6.17%$6.57
ZBH$2.27B$823.40M+83.14%$4.12
PHG$2.15B-$738.95MN/A-$0.79
SNN$1.29B$412.00M+4.64%$1.12
View Top Medical Device Stocks

PODD earnings dates

Next earnings date
Nov 6, 2025

Insulet Earnings Reports & History FAQ

What were Insulet's earnings last quarter?

On PODD's earnings call on Invalid Date, Insulet (NASDAQ: PODD) reported Q2 2025 earnings per share (EPS) of $0.32, up 88.1% year over year. Total PODD earnings for the quarter were $22.50 million. In the same quarter last year, Insulet's earnings per share (EPS) was $2.69.

If you're new to stock investing, here's how to buy Insulet stock.

When does Insulet report earnings?

The next PODD earnings call is Invalid Date. Add PODD to your watchlist to be reminded of Insulet's next earnings date.

Is Insulet profitable or losing money?

As of the last Insulet earnings report, Insulet is currently profitable. Insulet's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $236.10 million, a 40.27% decrease year over year.

What was PODD's earnings growth in the past year?

As of Insulet's earnings date in Invalid Date, Insulet's earnings has grown -40.35% year over year. This is 124.7 percentage points lower than the US Medical Devices industry earnings growth rate of 84.35%. PODD earnings in the past year totalled $236.10 million.

What are Insulet's earnings expectations?

The current EPS estimate for Insulet's earnings report in Invalid Date is $1.14.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.